Effects of granisetron and its combination with dexamethasone on cisplatin-induced delayed emesis in the ferret

被引:27
作者
Fukunaka, N
Sagae, S
Kudo, R
Endo, T
Hirafuji, M
Minami, M [1 ]
机构
[1] Hlth Sci Univ Hokkaido, Fac Pharmaceut Sci, Dept Pharmacol, Ishikari, Hokkaido 0610293, Japan
[2] Sapporo Med Univ, Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan
来源
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM | 1998年 / 31卷 / 05期
关键词
delayed emesis; granisetron; dexamethasone; ferret; cisplatin; 5-hydroxytryptamine;
D O I
10.1016/S0306-3623(98)00102-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Granisetron and its combination with dexamethasone for the treatment of delayed emesis following cisplatin (CDDP) administration were investigated using ferrets. 2. CDDP-induced emesis was significantly inhibited in both the granisetron group and the combined granisetron and dexamethasone group during the acute and delayed phase in terms of total emesis, latency to first emesis and duration of emesis. 3. Food and water consumption in the combined group of ferrets was significantly increased as compared with the CDDP control group. 4. 5-Hydroxytryptamine (5-HT) level was increased in the ileum and the 5-hydroxyindole acetic acid (5-HIAA) level was increased in the area postrema of ferrets after 3 days of CDDP administration. It is suggested that the antiemetic activity of granisetron and/or dexamethasone is not related to 5-HT levels in delayed emesis. 5. Both granisetron and its combination with dexamethasone are effective in CDDP-induced emesis, but combination treatment is more effective than granisetron alone for the duration of emesis in the delayed phase. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:775 / 781
页数:7
相关论文
共 49 条
[1]   PHYSIOLOGY OF NAUSEA AND VOMITING [J].
ANDREWS, PLR .
BRITISH JOURNAL OF ANAESTHESIA, 1992, 69 (07) :S2-S9
[2]   THE ABDOMINAL VISCERAL INNERVATION AND THE EMETIC REFLEX - PATHWAYS, PHARMACOLOGY, AND PLASTICITY [J].
ANDREWS, PLR ;
DAVIS, CJ ;
BINGHAM, S ;
DAVIDSON, HIM ;
HAWTHORN, J ;
MASKELL, L .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1990, 68 (02) :325-345
[3]  
Andrews PLR., 1993, EMESIS ANTICANCER TH, P111
[4]  
[Anonymous], EMESIS ANTICANCER TH
[5]  
BAXENDALE BR, 1993, ANAESTHESIA, V48, P961
[6]   THE ANTI-EMETIC POTENTIAL OF THE 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONIST BRL-43694 [J].
BERMUDEZ, J ;
BOYLE, EA ;
MINER, WD ;
SANGER, GJ .
BRITISH JOURNAL OF CANCER, 1988, 58 (05) :644-650
[7]   A RANDOMIZED TRIAL OF DEXAMETHASONE, LORAZEPAM AND PROCHLORPERAZINE FOR EMESIS IN PATIENTS RECEIVING CHEMOTHERAPY [J].
BISHOP, JF ;
MATTHEWS, JP ;
WOLF, MM ;
OLIVER, IN ;
REYNOLDS, S ;
WALPOLE, E ;
RISCHIN, D ;
BUCHANAN, L ;
TAN, LG .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (01) :47-50
[8]   ENDOTOXIN-STIMULATED OPIOID PEPTIDE SECRETION - 2 SECRETORY POOLS AND FEEDBACK-CONTROL INVIVO [J].
CARR, DB ;
BERGLAND, R ;
HAMILTON, A ;
BLUME, H ;
KASTING, N ;
ARNOLD, M ;
MARTIN, JB ;
ROSENBLATT, M .
SCIENCE, 1982, 217 (4562) :845-848
[9]  
CEROSIMO RJ, 1986, PHARMACOTHERAPY, V6, P118
[10]   METHYLPREDNISOLONE ENHANCES THE EFFICACY OF ONDANSETRON IN ACUTE AND DELAYED CISPLATIN-INDUCED EMESIS OVER AT LEAST 3 CYCLES [J].
CHEVALLIER, B ;
MARTY, M ;
PAILLARSE, JM .
BRITISH JOURNAL OF CANCER, 1994, 70 (06) :1171-1175